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The glucocorticoid-induced tumor necrosis factor (TNF) receptor-related gene (GITR; TNFRSF18) modu-
lates immune response activating coaccessory signals in T cells and is expressed at high levels in CD4CD25
cells. Its ligand (GITRL) is expressed in antigen-presenting cells, where it is capable of promoting signaling.
We investigated the role of GITR/GITRL interaction during disseminated candidiasis in GITR knockout
(GITR/) mice. GITR/ mice survived longer and had a significantly decreased yeast load in kidneys and
brain compared to GITR/ mice. Since protective immunity to the fungus is mediated by antigen-specific T
helper (Th) 1 cells, we studied in vitro cytokine production following infection. CD4 T cells of GITR/ mice
demonstrated a more efficient Th1 polarization as suggested by a two- to threefold decreased production of
interleukin- (IL-)4 and IL-10 and a four- to fivefold increased production of gamma interferon compared to
GITR/ mice. This effect was not due to differences in lymphocyte and dendritic cell (DC) subpopulations in
infected mice as demonstrated by flow cytometric studies. To verify whether DC activity was differently
modulated, DCs were cocultured with CD4 T cells in the presence of heat-inactivated Candida albicans. DCs,
cocultured with GITR/ CD4CD25 cells produced a lower amount of IL-12 than DCs cocultured with
GITR/ CD4CD25 T cells. These results suggest that GITR regulates susceptibility to systemic candidiasis
by negatively modulating IL-12 production and promoting polarization of CD4 T cells towards Th2 by analogy
with OX40, another TNF receptor superfamily member.
The glucocorticoid-induced tumor necrosis factor (TNF) re-
ceptor-related gene (GITR; TNFRSF18) encodes a 35- to 40-
kDa protein belonging to the TNF receptor superfamily (TN-
FRSF), cloned in a murine hybridoma T-cell line treated with
dexamethasone (18). Given the striking homology of the GITR
cytoplasmic region with other TNFRSF members (4-1BB,
OX40, CD27, and CD40), GITR and these molecules form a
new subfamily inside the TNFRSF (19, 29), characterized by
coactivating activity and involved in the regulation of T lym-
phocyte function (25, 33, 34). GITR is expressed at different
levels in normal T cells, including single-positive CD4 and
CD8 thymocytes and spleen and lymph node T cells (18, 19).
Upon T-cell activation, GITR is up-regulated in both CD4
and CD8 cells, suggesting it plays a role in the control of
T-cell activation and immune response development (18, 25).
Moreover, GITR is expressed at high levels in CD4CD25
regulatory T (Treg) cells (13, 26), which exert suppressor ac-
tivity on CD4CD25 effector T cells and are involved in
control of several autoimmune/inflammatory diseases. During
T-cell activation, GITR costimulus potentiates CD4CD25
effector activity and negatively modulates CD4CD25 Treg
cell suppressor activity (13, 19, 25, 26, 33). Consequently, T-cell
receptor/CD3-induced activation of T lymphocytes is deregu-
lated in GITR-deficient mice (GITR/), although no signif-
icant differences were observed in the relative composition of
lymphocyte subpopulations in the spleen and lymph nodes
between GITR/ and GITR/ mice (24).
GITR is activated by its ligand (GITRL), which is expressed
in antigen-presenting cells, including macrophages, immature
and mature dendritic cells (DCs), and B lymphocytes, but not
in resting and activated T cells (8, 19, 33, 35). After DC acti-
vation, GITRL is transiently up-regulated (33). Recently,
Choi’s group demonstrated that, after the GITR-GITRL in-
teraction, GITRL also delivers signals by means of its cytoplas-
mic domain (11, 27, 28).
Candida albicans is the leading cause of fungal opportunistic
diseases in humans. Intravenous infection of mice with C. al-
bicans blastospores causes a pathology that resembles the hu-
man one, characterized by active fungal replication in the kid-
ney, brain, and heart, with death usually resulting from kidney
failure (2). In murine systemic candidiasis, the development of
the T helper (Th) type 1 response is correlated with induction
of protective immunity to the fungal pathogen. In contrast, the
occurrence of the Th2 response is associated with pathology
progression (22).
Recent evidence suggests that Treg cells play a role in re-
sponses to infection. In fact, Treg cells may limit the magnitude
of effector responses, which may result in failure to adequately
control infection (3, 31, 32). In particular, in an experimental
model of murine candidiasis, a reduction of Treg cell activity
causes better control of the infection (16).
In this study, we investigated the role of GITR in the devel-
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opment of C. albicans infection using GITR/ mice. The
results indicate that GITR/ mice are more resistant to in-
fection than wild-type (GITR/) mice, due to an increase in
Th1 response.
MATERIALS AND METHODS
Animals. Sv129 GITR-deficient (GITR/) mice were generated by homolo-
gous recombination as previously described (24). Mice were maintained under
specific-pathogen-free conditions in the Animal Care Facility of the University of
Perugia. They were group housed under controlled temperature and photope-
riod (12-h:12-h light-dark cycle) and allowed unrestricted access to standard
mouse chow and tap water. Mice of both sexes were used at the age of 8 to 12
weeks. Protocols were approved by the Animal Study Committees of the Uni-
versity of Perugia according to governmental guidelines for animal care.
Infection. The origin and characteristics of the highly virulent C. albicans
(CA-6) strain used in this study have been previously described (23). For infec-
tion, C. albicans cells were washed twice in saline and diluted to the desired
density to be injected intravenously via the lateral tail vein in a volume of 0.5
ml/mouse. Littermate GITR/ and GITR/ mice were used in the experi-
ments. Infected animals were monitored for survival every day and at days 2 and
6 after infection for organ clearance. Quantification of fungal growth in the
organs of infected mice (four to six mice per group) was performed by plating
serial dilutions of homogenized organs in Sabouraud dextrose agar, and results
(mean  standard error of the mean) were expressed as CFU per organ.
Culture medium. The cells were cultured in RPMI 1640 supplemented with
10% heat-inactivated fetal bovine serum, streptomycin (100 g/ml), 10 mM
HEPES, 0.1% nonessential amino acids, 1 mM sodium pyruvate, and 50 M
2-mercaptoethanol (complete medium).
Cell cultures. Dendritic cells (at a concentration of 105 cells/ml) and CD4 or
CD4CD25 T cells (at a concentration of 106 cells/ml) were cocultured in 1 ml
of complete medium (24-well plates). Cocultures were stimulated with heat-
inactivated C. albicans (DC–C. albicans ratio, 1:10) for 18 h. C. albicans yeast
cells were inactivated by heating to 65°C for 1 h. The fungal inactivation was
confirmed by plating the suspension onto Sabouraud agar.
DCs (at a concentration of 105 cells/ml) and CD4CD25 T cells were cocul-
tured (DC–CD4CD25 ratio, 1:1 or 1:2) in 1 ml of complete medium (24-well
plates) and were stimulated with heat-inactivated C. albicans (DC–C. albicans
ratio, 1:10) for 18 h.
Cytokine production. Spleen cells (2  106 cells/ml in 1 ml of complete
medium in wells of flat-bottomed 24-well plates) were stimulated with heat-
inactivated C. albicans (spleen cell–C. albicans ratio, 1:10). CD4 T cells (1.25 
106 cells/ml) were plated in wells (24-well plates, 1 ml/well) on a layer of irradi-
ated splenocytes (5  106 cells/well) and cultured in the presence of heat-
inactivated C. albicans (CD4 cell–C. albicans ratio, 1:10) for 48 h. Interleukin-
(IL-)12p70, IL-10, IL-4, and gamma interferon (IFN-) were evaluated in cell
culture supernatant fluids according to a previously described method (25). The
antibodies (capture and detection) used for the evaluation of the above cytokines
were purchased from Pharmingen (San Diego, CA) and the enzyme-linked
immunosorbent assays were performed according to the manufacturer’s instruc-
tions.
Cell purification. CD4 T cells were purified by positive selection from spleen
of infected and noninfected mice using CD4 (L3T4) microbeads (Miltenyi Bio-
tech, Bologna, Italy), according to the manufacturer’s instructions. Microbeads
allow a purification level higher than 95% and do not activate cells.
CD4CD25 cells were purified from CD25-depleted spleen cells. For de-
pletion, spleen cells were incubated with phycoerythrin-conjugated anti-mouse
CD25 (IL-2 receptor  chain, p55) (clone 7D4), and the stained cells were
incubated with anti-phycoerythrin microbeads (Miltenyi Biotech). The depletion
of CD25 was detected by flow cytometry (less than 0.1% of the depleted cells
expressed CD25). After CD25 cell depletion, CD4 were isolated using CD4
(L3T4) microbeads.
CD4CD25 cells were purified from lymph nodes by using a CD4CD25
T-cell isolation kit (Miltenyi Biotech) following the manufacturer’s instructions.
Briefly, after isolating CD4 T cells with the (L3T4) microbeads, the CD25
phycoerythrin-labeled cells were magnetically labeled with anti-phycoerythrin
microbeads according to the manufacturer’s instructions (25). The cell suspen-
sion was loaded on a column, which was placed in the magnetic field of a MACS
separator. The retained cells eluted from the column were CD4CD25 cells.
To achieve the highest purities, two consecutive column runs were performed.
The purity of T-cell subpopulations was 98% as evaluated by flow cytometry
analysis.
DCs were separated from spleens of wild-type or GITR/ mice using N-418
monoclonal antibody-conjugated microbeads (Miltenyi Biotech), and magnetic
separation was done according to manufacturer’s instructions.
Flow cytometry analysis. We pelleted 5  105 cells in a round-bottomed
centrifuge tube, resuspended in 10 l of labeling buffer containing either fluo-
rescein isothiocyanate- or phycoerythrin-conjugated antibodies, and incubated at
4°C for 20 min in the dark. The cells were then washed twice and resuspended
in 1X phosphate-buffered saline. The samples were then analyzed using a FAC-
Scan flow cytometer (Becton Dickinson, Sunnyvale, CA).
The following monoclonal antibodies were used: fluorescein isothiocyanate-
conjugated anti-mouse CD3ε (clone 145-2C11), fluorescein isothiocyanate-con-
jugated anti-mouse CD8 (clone 53-6.7), phycoerythrin-conjugated anti-mouse
CD4 (L3T4) (clone H129.19), and phycoerythrin-conjugated anti-mouse B220.
All monoclonal antibodies were purchased from Pharmingen.
For flow cytometric analysis of dendritic subpopulation, purified DCs (106/ml)
from the spleens of GITR/ and GITR/ mice before and after infection with
C. albicans, were washed twice in phosphate-buffered saline, fixed in 10% for-
malin, and labeled for 40 min on ice with phycoerythrin-conjugated rat mono-
clonal antibody to mouse CD8 (Chemicon Int., Temecula, CA; clone KT15,
isotype immunoglobulin G2a). After incubation, cells were washed twice in
fluorescence buffer (phosphate-buffered saline containing 0.5% bovine serum
albumin and 0.4% sodium azide), resuspended, and analyzed by FACScan. Data
are expressed as percentage of positive cells.
Intracellular staining. For analysis of intracellular IL-12, purified DCs (105/
ml) were cocultured overnight in complete medium at 37°C with 5% CO2 with
autologous or heterologous CD4 T cells (106/ml) from naı¨ve or C. albicans
CA-6-infected mice in the presence of heat-inactivated CA-6. After incubation
the cells were washed twice in phosphate-buffered saline, fixed in 10% formalin,
permeabilized for 10 min at room temperature with 0.1% saponin (Sigma Chem-
ical Co., St Louis, MO) in phosphate-buffered saline, and labeled for 40 min on
ice with biotin goat anti-mouse interleukin-12 (Cederlane, Hornby, Ontario,
Canada). After incubation, cells were reacted for 40 min on ice with avidin-
fluorescein isothiocyanate, washed with phosphate-buffered saline containing
0.1% saponin, resuspended in fluorescence buffer and analyzed by FACScan.
Data are expressed as percentage of positive cells.
Statistical analysis. Student’s t test was used to determine the statistical
significance of differences in organ clearance and in in vitro assays. Data reported
were pooled from three experiments with similar results. Survival data were
analyzed by the Mantel-Cox logrank test. Significance was defined as P 	 0.05.
RESULTS
GITR/ mice are more resistant to systemic C. albicans
infection. To investigate the role of GITR in C. albicans infec-
tion, we intravenously infected GITR/ and GITR/ mice
with virulent C. albicans cells. As shown in Fig. 1A, GITR/
mice survived significantly longer than GITR/ mice (21 days
median survival time of GITR/ versus 13 days of GITR/
mice, P 	 0.01). At the end of the monitoring period, all mice
of both groups were dead.
Fungal growth in kidneys and brain, the target organs of
murine candidiasis, was also determined. For this purpose,
infected mice were sacrificed at day 2 and day 6 postinfec-
tion, and kidney and brain homogenates were plated on Sab-
ouraud agar. The fungal burden was expressed as CFU/organ.
GITR/ mice showed significantly less (P 	 0.01) fungal
burden in kidneys with respect to control mice at both time
points (Fig. 1B, left). No differences were found in fungal
growth between GITR/ and GITR/ mice at day2 in the
brain. However, at day 6 GITR/ mice showed a decrease
(P	 0.01) in fungal burden compared to control mice (Fig. 1B,
right).
These results indicate that GITR/ mice are less suscepti-
ble to systemic C. albicans infection than GITR/ mice be-
cause of more efficient clearance of C. albicans.
C. albicans infection increases Th1 responses in GITR/
mice. Since low susceptibility to C. albicans infection is linked
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to Th1 response, while high susceptibility is linked to Th2
response, we evaluated cytokine production of T cells. In par-
ticular, IL-4, IL-10, IL-12 p70, and IFN- levels were detected
on supernatants of spleen cells from C. albicans infected mice
(day 6) after in vitro restimulation with heat-inactivated C.
albicans. We found that the levels of IL-4 and IL-10 were
significantly lower (P 	 0.05) in GITR/ mice than in
GITR/ mice, while IFN- production was significantly
higher (P 	 0.05) in GITR/ mice compared to GITR/
mice (Fig. 2A). IL-12 p70 was slightly, but not significantly,
increased in GITR/ mice. Similar results were obtained us-
ing purified spleen CD4 T cells (Fig. 2B), suggesting that a
higher percentage of Th1 polarized T cells are present in the
spleen of GITR/ mice.
These results show that the better outcome of C. albicans
infection in GITR/ mice is correlated to an increase in Th1
responses.
Phenotypic analysis of GITR/ and GITR/ mice. To
evaluate whether the different cytokine patterns were due to a
different lymphocyte phenotype developed in response to can-
didiasis, we performed flow cytometric analysis of spleens from
GITR/ and GITR/ mice 6 days after systemic infection
with C. albicans. No differences were observed in terms of
percentage of B, T, CD4 and CD8 cells in GITR/ mice
compared to GITR/ mice (data not shown).
Because CD8 DCs stimulate Th2 responses, whereas
CD8 DCs produce IL-12 and induce Th1 responses, we
investigated the phenotype of DCs in noninfected and infected
mice. However, no differences in the percentage of CD8
cells from the spleens of GITR/ and GITR/ mice before
infection and on day 6 of infection were observed (data not
shown).
FIG. 1. Decreased susceptibility to systemic C. albicans infection in
GITR/ mice. GITR/ and GITR/ mice were intravenously in-
fected with 5  105 C. albicans cells. A: Survival was assessed daily for
40 days. % survival of infected mice was evaluated according to Man-
tel-Cox Logrank test and the difference between GITR/ and
GITR/ mice resulted significant (P 	 0.01). B: For the quantifica-
tion of fungal burden, mice were sacrificed 2 and 6 days after infection,
serial dilutions of organ homogenates were plated onto Sabouraud
agar, and CFU were counted after 48 h incubation. Fungal burden is
expressed as CFU/organ. Data represent means  standard error of
the mean of data from three independent experiments. **, P 	 0.01,
GITR/ versus GITR/, according to Student’s t test.
FIG. 2. In vitro production of cytokines in GITR/ and GITR/ mice during systemic C. albicans infection. GITR/ and GITR/ mice
were infected with 5  105 C. albicans cells and 6 days after infection spleen cells (A) or CD4 T cells (B) were harvested. The cells were
restimulated with heat-inactivated C. albicans (cell–C. albicans ratio, 1:10). Following 48 h incubation supernatants were harvested and Th1 (IL-12
p70 and IFN-) and Th2 (IL-4 and IL-10) cytokines were measured by enzyme-linked immunosorbent assay. Data represent means  standard
error of the mean of data from three independent experiments. *, P 	 0.05 GITR/ versus GITR/, according to Student’s t test.
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These results indicate that, during C. albicans infection, lym-
phocyte and DC subpopulations are present at comparable
levels in GITR/ and GITR/ mice.
GITR/ DCs produce more IL-12 than GITR/ DCs. To
gain insight into the mechanisms involved in the increase of
Th1 response in GITR/ mice during candidiasis, we per-
formed in vitro experiments by coculturing DCs with CD4 T
cells from naive and infected mice in the presence of heat-
inactivated C. albicans. Intracellular staining of IL-12 shows
that GITR/ DCs produce a significantly higher level of this
cytokine than GITR/ DCs (P 	 0.05), when cocultured with
CD4 T cells from infected mice (Fig. 3, column 5 versus 4).
Interestingly, no differences were observed in cocultures of
DCs with CD4 T cells from noninfected mice (Fig. 3, column
2 versus 1).
To investigate whether the increased IL-12 production was
due to a GITR/ DC phenotype different from that of
GITR/ DCs, we cocultured GITR/ DCs with CD4 T
cells from GITR/ mice. Figure 3 shows that IL-12 produc-
tion of GITR/ DCs in heterologous cocultures (GITR/
DCsGITR/ CD4 T cells, column 6) was significantly less
(P 	 0.05) than in autologous cocultures (GITR/ DCs 
GITR/ CD4 T cells, column 5), reaching the levels of
GITR/ autologous cocultures (GITR/ DCs  GITR/
CD4 T cells, column 4). Therefore, during candidiasis,
GITR/ CD4 T cells inhibit IL-12 production in DCs.
Activated CD4 T cells and Treg cells inhibit IL-12 produc-
tion. GITR is expressed at basal levels in CD4CD25 T cells
and at high levels in CD4CD25 T cells either derived from
CD4CD25 cells following activation (effector T cells) or
constitutively expressing CD25 (Treg cells) (13, 18, 19, 26).
Therefore, we performed experiments to evaluate whether the
modulation of IL-12 production in DCs was mainly due to
CD4CD25 T cells or to CD4CD25 cells. For that pur-
pose, DCs were cocultured with purified CD4 T-cell popula-
tion (including both CD25 and CD25 cells) or purified
CD4CD25 T cells from spleen of infected mice in the pres-
ence of heat-inactivated C. albicans. Figure 4 shows that in
GITR/ DC depletion of CD4CD25 cells significantly in-
creased (P 	 0.05) the IL-12 production (column 3 versus 1),
that reaches levels similar to those observed in GITR/ DCs
(columns 2 and 4). In fact, no significant differences of IL-12
production were observed in GITR/ and GITR/ DCs
when cocultured with autologous CD4CD25 (column 4 ver-
sus 3). In summary, only cells expressing high levels of GITR
(GITRhigh) were able to negatively modulate IL-12 production
in DCs (Fig. 4, column 1), while both GITRlow and GITR/
cells failed to negatively modulate IL-12 production (Fig. 4,
columns 2, 3, and 4).
Since it is likely that the phenotype of CD4CD25 cells is
modified in several ways during infection, we wondered
whether the difference in the modulation of IL-12 production
in DCs was due to the high level of expression of GITR in T
cells from infected mice or to the expression of different sur-
face markers in response to infection in GITR/ and
GITR/ T cells. Therefore, to verify whether GITR ex-
pressed at high levels in nonprimed cells was able to modulate
IL-12 production in DCs, we used CD4CD25 cells from
noninfected mice (Treg cells), which express constitutively high
levels of GITR. These cells, from GITR/ and GITR/
mice, were cocultured with autologous DCs in the presence of
heat-inactivated C. albicans. As shown in Fig. 5, GITR/ DCs
cocultured with GITR/ Treg produce significantly more
(P 	 0.05) IL-12 than GITR/ DCs cocultured with
GITR/ Treg both at 1:1 and 1:2 DC/Treg cell ratio. These
results further suggest that high levels of GITR are responsible
for a decreased IL-12 production in DCs.
DISCUSSION
Here we show that GITR/ mice are more resistant to C.
albicans infection compared to GITR/ mice, and this is due
to a more efficient clearance of the fungus. The increased
FIG. 3. Expression of IL-12 in DCs is modulated by GITR/
CD4 T cells from infected mice. DCs from GITR/ and GITR/
mice were cocultured with autologous or heterologous CD4 T cells
from untreated or infected mice in the presence of heat-inactivated C.
albicans. IL-12 production was evaluated by DC intracellular staining.
Data represent means  standard error of the mean from three inde-
pendent experiments. *, P 	 0.05 column 5 versus 4 and 5 versus 6,
according to Student’s t test.
FIG. 4. Increase of IL-12 production after depletion of GITR/
CD4CD25 T cells. DCs from GITR/ and GITR/ mice were
cocultured with autologous CD4 or CD4CD25 T cells from in-
fected mice in the presence of heat-inactivated C. albicans. IL-12
production was evaluated by DC intracellular staining. Data represent
means  standard error of the mean from three independent experi-
ments. *, P 	 0.05 column 2 versus 1 and 3 versus 1, according to
Student’s t test.
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resistance is correlated to a skew to a Th1 phenotype in
GITR/ mice, related, at least in part, to increased IL-12
production by DCs.
GITR is a molecule participating in the immune response by
costimulating CD4 and CD8 effector T cells (19, 25, 33) and
abolishing the suppressor activity of Treg cells (13, 19, 26).
Accordingly, GITR is involved in autoimmune diseases and
potentiates antiviral and antitumor responses (4, 19). How-
ever, the data presented here cannot be explained by looking at
GITR as a molecule stimulating the immune system in all its
components. In fact, GITR/ mice demonstrate a longer sur-
vival time than control mice because of a higher efficiency of C.
albicans clearance. Thus, GITR expression hampers the reac-
tion against C. albicans. This is not surprising since several
TNFRSF members with costimulatory function do not operate
as generic boosters of cell activation, but as specialized players
of immune system response, favoring or depotentiating im-
mune response to specific pathogens. As an example, the
CD40/CD40L system potentiates host defense against C. albi-
cans and Cryptococcus neoformans (15, 21), while the blockade
of OX40/OX40L ameliorates progressive leishmaniasis (1).
A recent study demonstrates that GITR triggering potenti-
ates the graft-versus-host disease mediated by CD8CD25
cells while inhibiting the graft-versus-host disease mediated by
CD4CD25 cells (14), suggesting that GITR is a sophisti-
cated player in the immune response. The data here presented
assign another specialized function to GITR. It is known that
Th1/Th2 polarization derives from the balance among cyto-
kines: high levels of IFN- and IL-12 correlate with a Th1
response, while high levels of IL-4 and IL-10 correlate with a
Th2 response. The prevalent Th1 polarization in infected
GITR/ mice demonstrated by a lower production of IL-4
and IL-10 and a higher production of IFN- suggests that
GITR/GITRL system favors Th2 polarization in C. albicans
infection. This is in line with the function of other TNFRSF
members, such as OX40 and CD30, that bias cytokine produc-
tion to Th2 polarization in several infection models (1, 7, 10,
34). However, caution has to be applied in drawing conclusions
from in vitro data for several reasons, including, in this case,
the possibility that cell stimulation by heat-inactivated C. albi-
cans may not cause the same effects obtained with virulent C.
albicans. Further in vivo studies will be performed to confirm
our hypothesis.
We also focused on how GITR absence was able to skew
cytokine production to Th1 in C. albicans infection. It is well
FIG. 5. Unprimed Treg cells from GITR/ mice modulate pro-
duction of IL-12 in DCs. DCs from C. albicans-infected GITR/ and
GITR/ mice were cocultured at the indicated ratio (DC:Treg) with
autologous CD4CD25 Treg cells from noninfected mice in the pres-
ence of heat-inactivated C. albicans. IL-12 production was evaluated by
intracellular staining on DCs. Data represent means  standard error
of the mean from three independent experiments. *, P 	 0.05
GITR/ versus GITR/, according to Student’s t test.
FIG. 6. Hypothetical mechanisms by which GITR lack promotes a
more efficient clearance of C. albicans. In panel A, the low level of
IL-12 observed following T-cell receptor stimulation by C. albicans
antigens (Ags) in the presence of GITR/GITRL signaling may be
explained by three (1, 2, and 3) concurrent intracellular pathways
activated following binding of GITRL (expressed on antigen present-
ing cells) with GITR (expressed at high levels in Treg and activated T
cells). IL-12 and other ligands (Ls), including other cytokines (Cks),
activate the respective receptors (IL-12R and other R’s) either in
antigen-presenting cells or in activated CD4 T cells, skewing to Th2
cytokine production. Also, activation of GITR in activated CD4 cells
(4) might play a role. In panel B, the lack of GITR causes a lack of both
GITR and GITRL signaling, high IL-12 levels, and cytokine produc-
tion promoting a prevalent Th1 polarization. The high efficiency of C.
albicans clearance in GITR/ mice might be obtained in GITR/
mice using antibodies or fusion proteins with antagonist function.
7506 AGOSTINI ET AL. INFECT. IMMUN.
known that CD4 polarization is favored by messages deliv-
ered by antigen-presenting cells, including DCs, during CD4
T-cell priming, and that T cells deliver signals to DCs favoring
their differentiation. Several members of TNFRSF (including
GITR and OX40) are expressed on T cells, and their ligands
(including GITRL and OX40L) are expressed on antigen-pre-
senting cells (10, 19, 35). OX40L ligation on CD40-activated
monocyte-derived antigen-presenting cells enhances cytokine
production including that of IL-12 (20). GITRL is also able to
promote signaling as demonstrated in macrophages and oste-
oclasts (11, 27, 28).
Here we demonstrate that autologous DCs cocultured with
GITR/ CD4CD25 T cells from both infected and nonin-
fected mice produce a lower amount of IL-12 compared to
DCs cocultured with GITR/ T cells (Fig. 4 and 5). This
effect is not due to differences between GITR/ and
GITR/ DCs since GITR/ and GITR/ DCs cocultured
with GITR/ CD4 T cells from infected mice (thus includ-
ing activated CD4CD25 T cells) produced a similar amount
of IL-12 (Fig. 3). Thus, we may hypothesize that GITR triggers
GITRL present on DCs and promotes a decreased IL-12 pro-
duction. Interestingly, CD4 T cells from noninfected
GITR/ mice did not negatively modulate IL-12 production
in DCs, probably as a consequence of the lower percentage of
GITRhigh T cells compared to that present in CD4 cells from
infected mice. In fact, GITR expression is impressively up-
regulated during T-cell activation (18, 24, 25).
A different explanation of the in vitro results may be that
GITR/ CD4CD25 cells are different from GITR/
CD4CD25 cells concerning their activity and/or the expres-
sion of surface markers other than GITR. Alternatively, GITR
triggering, modulating TNFR-associated factors (TRAFs) and
NF-
B activity (5, 6, 9, 19), may induce the expression of
surface markers other than GITR in CD4CD25 cells, which,
in turn, modulate DC function. A clear picture will be drawn
only when GITRL/ mice and antibodies against GITRL
and/or GITR fusion proteins clearly functioning as agonists are
available.
We here demonstrate that GITR/GITRL system activation
negatively modulate the synthesis of IL-12 in DCs, contributing
to Th2 polarization. However, GITR triggering in responder
CD4 T cells may also directly cause a Th2 polarization, as
suggested for another TNFRSF member, OX40 (1, 12). A
summary of the possible mechanisms underlying the role of the
GITR/GITRL system in Th2 polarization is presented in Fig.
6.
Treg cells are crucial in the response to infection. In fact,
Treg cells may limit the magnitude of effector responses, which
result in failure to adequately control infection (3, 32). As an
example, mice lacking toll-like receptor (TLR) 2 are more
resistant to C. albicans infection, despite the pivotal role of
TLR2 in the recognition of C. albicans, due to a 50% decrease
in the Treg cells in TLR/ mice (16). Ronchetti et al. have
found a lower percentage (about 25%) of Treg cells in
GITR/ compared to GITR/ Sv129 mice that, however,
resulted in nonsignificance upon statistical evaluation (19, 25).
Stevens et al. also found in GITR/ mice of mixed back-
ground a difference (about 33%) in Treg presence (30). Thus,
although our experiments have been performed in Sv129 mice,
GITR/ mice may have a lower percentage of Treg cells and
this may contribute to the more efficient clearance of C. albi-
cans.
Finally, this work supports the hypothesis that GITR/
GITRL system hampers C. albicans clearance by skewing to
Th2 phenotype. The same effect has been described for OX40/
OX40L system in other models (1, 7, 10). This is not surprising
if we consider the striking homology in the cytoplasmic do-
mains of the two receptors (17). Furthermore, we have ana-
lyzed the short cytoplasmic domains of GITRL and OX40L
and here we show that they share a 70% similarity and a 55%
identity, with an acid region at the beginning of the protein
(E-x [0, 1]-E-x[4, 5]-[ED]) and a strong basic region (R-x[1,
2]-[RK]-x[1]-K-K) next to the transmembrane domain (Fig. 7).
The homology of both receptors and ligands suggests that the
GITR/GITRL and OX40/OX40L systems may play redundant
and/or integrated functions. Further studies will be devoted to
addressing the possible interacting functions of GITR/GITRL
and OX40/OX40L systems in infection resistance.
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